Clinical Trials

Accrual Status
Limit to SWOG Trials

1044 Results

View
Status Trial Number Title Activated Closed Accrual Phase Published
Closed SWOG-8642 Recombinant Human Interferon-Gamma for the Adjuvant Treatment of High Risk Malignant Melanoma After Surgical Excision of the Primary Lesion 6/1/1987 5/15/1990 100% Published
Closed SWOG-9304 (INT-0144) RECTAL 3/1/1994 8/1/2000 98% Published
Closed S0304 RECTAL 8/1/2004 2/1/2006 0%
Closed S0329 Recurrent of Metastatic Squamous Cell Carcinoma of the Head and Neck 1/1/2005 1/1/2007 100% Published
Closed S0420 Recurrent or Metastatic Head and Neck Cancer 10/1/2004 100% Published
Closed S0618 Recurrent or Metastatic Squamous Cell 5/1/2006 1/1/2008 95% Published
Closed S9902 Recurrent, Refractory or Metastatic 11/15/1999 1/1/2001 97% Published
Closed S9807 Recurrent, Refractory or Metastic 9/1/1998 2/15/2004
Closed S0308 Reduction of Skeletal Events in Advanced Breast Cancer 5/15/2006 6/8/2006 0%
Closed S9922 Refractory Myeloma 4/15/2000 11/1/2001 6%
Closed SWOG-8461 Registration and Evaluation of Patients Aged 55 and Over with Unfavorable Histology NHL 6/1/1984 3/20/1986 Published
Closed S0010 Relapsed/Refractory Non T-Cell ALL 7/15/2000 3/15/2004 48%
Closed SWOG-7315/16 Remission Induction for Adult Acute Leukemia with Ten-day OAP Remission Maintenance with OAP vs OAP plus BCG 7/6/1973 1/1/1977 Published
Closed SWOG-9230 Renal 6/1/1993 5/1/1995 100% Published
Closed SWOG-8949 Renal 3/1/1991 10/1/1998 100% Published
Closed SWOG-9451 Resectable Head and Neck 4/12/1996 12/1/2001 87% Published
Closed SWOG-7823/24/25/26 ROAP-AdOAP in Acute Adult Leukemia 8/4/1978 9/10/1982 Published
Closed S1513 RPh II of 2nd Line FOLFIRI w/ or w/o Veliparib (ABT888) in met panc cancer 9/1/2016 86%
Closed S1613 RPh II Pertuzumab+Trastuzumab vs CETIRI mCRC w/HER2 amp 10/9/2017 12/31/2021 42%
Closed S1304 RPII Dex + High or Low Dose Carfilzomib for R/R MM 10/18/2013 5/15/2016 100%
Scroll Table